Profil
Yves Cornellier founded Alethia Biotherapeutics, Inc. in 2002, where he is working as President, Chief Executive Officer & Director from 2002.
Mr. Cornellier also founded Seyvika Pharmaceuticals.
Mr. Cornellier also formerly worked at 9342-8530 Québec, Inc., as Director, LAB International, Inc., as Senior Vice President-Business Development, Theratechnologies, Inc., as VP-Business Development & Commercialization, Miles Laboratories, Inc., as Principal, Abbott Laboratories Ltd., as Senior Marketing Manager, and Glaxo Canada, Inc., as Principal.
Aktive Positionen von Yves Cornellier
| Unternehmen | Position | Beginn |
|---|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Gründer | 01.01.2002 |
Ehemalige bekannte Positionen von Yves Cornellier
| Unternehmen | Position | Ende |
|---|---|---|
Miles Laboratories, Inc.
Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Glaxo Canada, Inc. | Corporate Officer/Principal | - |
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, develops and sells pharmaceutical and nutritional products | Vertrieb & Marketing | - |
| THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
9342-8530 Québec, Inc.
9342-8530 Québec, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products for diagnosis of cancer | Health Technology |
LAB International, Inc.
LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
Seyvika Pharmaceuticals
Seyvika Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Researches and develops drugs for the treatment of asthma | Commercial Services |
Miles Laboratories, Inc.
Miles Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Abbott Laboratories Ltd.
Abbott Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures, develops and sells pharmaceutical and nutritional products | Health Technology |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
Glaxo Canada, Inc. |
















